{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:11:07Z","timestamp":1761340267672,"version":"3.44.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,7]]},"DOI":"10.7759\/cureus.91764","type":"journal-article","created":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:30:10Z","timestamp":1757237410000},"source":"Crossref","is-referenced-by-count":1,"title":["Drug-Induced Lung Injury With Drug Eruption Due to Apalutamide Followed by Switch to Bicalutamide: A Case Report"],"prefix":"10.7759","author":[{"given":"Nao","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanayuki","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomiko","family":"Sunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"NCCN. Homepage. (2025). Accessed: September 2, 2025: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2021.05.006","article-title":"Apalutamide-induced severe interstitial lung disease: a report of two cases from Japan","volume":"59","author":"Kobe H","year":"2021","unstructured":"Kobe H, Tachikawa R, Masuno Y, et al.. Apalutamide-induced severe interstitial lung disease: a report of two cases from Japan. Respir Investig. 2021, 59:700-5. 10.1016\/j.resinv.2021.05.006","journal-title":"Respir Investig"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.655605","article-title":"Evaluation of potential complications of interstitial lung disease associated with antiandrogens using data from databases reporting spontaneous adverse effects","volume":"12","author":"Nawa H","year":"2021","unstructured":"Nawa H, Niimura T, Hamano H, et al.. Evaluation of potential complications of interstitial lung disease associated with antiandrogens using data from databases reporting spontaneous adverse effects. Front Pharmacol. 2021, 12:655605. 10.3389\/fphar.2021.655605","journal-title":"Front Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5980\/jpnjurol.110.36","article-title":"Drug-induced interstitial lung disease during combined androgen blockade with bicalutamide and leuprorelin acetate for prostate cancer","volume":"110","author":"Maeda K","year":"2019","unstructured":"Maeda K, Osafune T, Masuda Y, et al.. Drug-induced interstitial lung disease during combined androgen blockade with bicalutamide and leuprorelin acetate for prostate cancer. Nihon Hinyokika Gakkai Zasshi. 2019, 110:36-40. 10.5980\/jpnjurol.110.36","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.JNMS.2022_89-503","article-title":"Maculopapular drug eruption caused by apalutamide: Case report and review of the literature","volume":"89","author":"Katayama H","year":"2022","unstructured":"Katayama H, Saeki H, Osada SI. Maculopapular drug eruption caused by apalutamide: Case report and review of the literature. J Nippon Med Sch. 2022, 89:550-4. 10.1272\/jnms.JNMS.2022_89-503","journal-title":"J Nippon Med Sch"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7100356","article-title":"Drug-induced interstitial lung disease: a systematic review","volume":"7","author":"Skeoch S","year":"2018","unstructured":"Skeoch S, Weatherley N, Swift AJ, et al.. Drug-induced interstitial lung disease: a systematic review. J Clin Med. 2018, 7:10.3390\/jcm7100356","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118509","article-title":"Drug metabolism, danger signals, and drug-induced hypersensitivity","volume":"108","author":"Gruchalla RS","year":"2001","unstructured":"Gruchalla RS. Drug metabolism, danger signals, and drug-induced hypersensitivity. J Allergy Clin Immunol. 2001, 108:475-88. 10.1067\/mai.2001.118509","journal-title":"J Allergy Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/331620-drug-induced-lung-injury-with-drug-eruption-due-to-apalutamide-followed-by-switch-to-bicalutamide-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:30:12Z","timestamp":1757237412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/331620-drug-induced-lung-injury-with-drug-eruption-due-to-apalutamide-followed-by-switch-to-bicalutamide-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,7]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.91764","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,7]]}}}